No Data
Yunnan jianzhijia health-chain (605266.SH): Received support for a special loan to repurchase shares.
On November 25, Gelonghui reported that yunnan jianzhijia health-chain (605266.SH) announced that according to the "Notice from the People's Bank of china, the Financial Regulatory Authority, and the China Securities Regulatory Commission regarding the establishment of share buyback and shareholding re-loan-related matters," recently, China Construction Bank Co., Ltd. Kunming branch completed the loan approval, agreeing to provide the company with a special loan for share buyback of no more than 70 million yuan, with a loan term of 1 year. The funds for this share buyback will come from the company's own funds and the special loan for share buyback.
Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Shares Leap 25% Yet They're Still Not Telling The Full Story
A-share midday report: Chinext price index up 1.78%, over 3000 stocks rise, pharmaceutical commerce concept leads the gains.
By the midday closing, the Shanghai Composite Index fell by 0.06%, the Shenzhen Component Index rose by 1.02%, and the chinext price index rose by 1.78%.
Here's Why Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Has A Meaningful Debt Burden
Yunnan Jianzhijia Health-chain (605266.SH): Cumulative repurchase of 0.48% of the company's shares
On November 1st, Jianzhijia Health-Chain (605266.SH) announced that, as of October 31, 2024, the company has repurchased a total of 748,000 shares of the company through the Shanghai Stock Exchange through centralized competitive trading, accounting for 0.48% of the current total share capital of 156,660,808 shares. The lowest price for the repurchase transaction was 18.21 yuan/share, the highest price was 23.04 yuan/share, and the total amount of funds used was 16.3477 million yuan.
Third Quarter Report 2024
Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Looks Inexpensive But Perhaps Not Attractive Enough
